Investors

Financial Highlights

Net sales, operating profit, net income, capital expenditure, and R&D expenses

Performance

  • Net Sales
  • Operating Income
  • Net Income (loss)
  • R&D Expenses
  • Capital Expenditure
  • Depreciation and Amortization
  • Total Net Assets and Total Assets
  • Equity Ratio
  • Return on Equity (ROE)
Items 2016
(IFRS)
2015
(IFRS)
2014
(IFRS)
2013
( JGAAP)
2012
( JGAAP)
Net sales 355,316 355,320 370,327 352,710 305,752
Operating income 19,247 4,327 14,461 18,170 10,473
Operating income margin [%] 5.4 1.2 3.9 5.2 3.4
Ordinary income(loss) - - - 20,390 13,561
Profit (loss) attributable to owners of the parent/Net Income(loss) 14,544 3,161 8,036 12,761 7,789
Ratio of profit to equity attributable to owners of the parent/Return on Equity 9.3 - 5.1 9.7 7.3
Cash flows from operating activities 31,153 19,958 22,335 28,788 18,984
Cash flows from investing activities 21,337 20,320 30,658 36,078 36,125
Cash flows from financing activities 969 3,395 555 5,708 8,529
R&D expenses 7,621 7,760 8,910(※) 6,916 5,468
Capital expenditure 18,200 21,300 29,785(※) 29,908 39,215
Equity attributable to owners of the parent/Total Net Assets 164,299 148,278 169,307 153,997 116,435
Total assets 381,326 359,002 387,877 361,083 327,912
Ratio of equity attributable to owners of the parent to total assets/Equity Ratio [%] 43.1 41.3 43.6 41.2 34.5

※R&D expenses and Capital ecpenditure of FY2014: JGAAP

資料ダウンロード

【PDF】brief investor summary [000 KB]

【PDF】財務データ [000 KB]

このページの先頭へ